TTPH - Tetraphase Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 521.9M
Enterprise Value 3-29.69M
Trailing P/E N/A
Forward P/E 1-0.42
PEG Ratio (5 yr expected) 10.00
Price/Sales (ttm)1.20
Price/Book (mrq)0.34
Enterprise Value/Revenue 3-1.62
Enterprise Value/EBITDA 60.43

Trading Information

Stock Price History

Beta (3Y Monthly) 1.87
52-Week Change 3-86.65%
S&P500 52-Week Change 36.80%
52 Week High 33.6600
52 Week Low 30.4000
50-Day Moving Average 30.5997
200-Day Moving Average 31.0329

Share Statistics

Avg Vol (3 month) 3604.58k
Avg Vol (10 day) 3419.43k
Shares Outstanding 552.86M
Float 53.93M
% Held by Insiders 10.61%
% Held by Institutions 145.24%
Shares Short (Jun 28, 2019) 44.04M
Short Ratio (Jun 28, 2019) 44.9
Short % of Float (Jun 28, 2019) 47.61%
Short % of Shares Outstanding (Jun 28, 2019) 47.45%
Shares Short (prior month May 31, 2019) 42.67M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-384.89%

Management Effectiveness

Return on Assets (ttm)-36.85%
Return on Equity (ttm)-80.10%

Income Statement

Revenue (ttm)18.29M
Revenue Per Share (ttm)0.34
Quarterly Revenue Growth (yoy)-32.70%
Gross Profit (ttm)-36.1M
EBITDA -69.72M
Net Income Avi to Common (ttm)-70.07M
Diluted EPS (ttm)-1.3210
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)87.56M
Total Cash Per Share (mrq)1.61
Total Debt (mrq)34.53M
Total Debt/Equity (mrq)54.89
Current Ratio (mrq)7.28
Book Value Per Share (mrq)1.17

Cash Flow Statement

Operating Cash Flow (ttm)-60.85M
Levered Free Cash Flow (ttm)-41.09M